The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.
Results from the phase 3 VERIFY study supported the filing, showing that the drug improved hematocrit levels and lowered the frequency of required blood removals.
While we cannot ignore the wider challenges facing the NHS, the SOHO UK programme highlights the extraordinary pace of progress in haematology. Alongside sessions showcasing emerging science, others are firmly grounded in the realities of everyday clinical practice, including the management of disease in young, pregnant, and elderly patients, Dr. Tom Coats writes.
The DIDACT Foundation was established with the mission to expand structured training and mentoring opportunities in clinical trial delivery for trainee UK haematologists.
SOHO UK is intended to set a precedent as the start of a continuing platform that will return at regular intervals and provide a forum for UK clinicians, trainees, and researchers to engage with international colleagues, according to meeting organisers.
Prof. Kate Cwynarski, MD, PhD, joined SOHO Insider podcast host Megan Melody, MD, for a discussion previewing lymphoma sessions she will lead at the inaugural
To access the SOHO Career Center click the following link.
